HUT36109A - New pharmaceutical preparations containing valeptoriate-hydrine - Google Patents

New pharmaceutical preparations containing valeptoriate-hydrine

Info

Publication number
HUT36109A
HUT36109A HU842912A HU291284A HUT36109A HU T36109 A HUT36109 A HU T36109A HU 842912 A HU842912 A HU 842912A HU 291284 A HU291284 A HU 291284A HU T36109 A HUT36109 A HU T36109A
Authority
HU
Hungary
Prior art keywords
acid
stands
beta
hydroxy
carbon atoms
Prior art date
Application number
HU842912A
Other languages
Hungarian (hu)
Other versions
HU201044B (en
Inventor
Peter W Thies
Samuel David
Insa Hell
Klaus U Wolf
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of HUT36109A publication Critical patent/HUT36109A/en
Publication of HU201044B publication Critical patent/HU201044B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. Claims for the contracting States : BE, CH, DE, FR, GB, IT, LI, NL Use of polyacyloxycyclopenta(c)pyran compounds of the general formula I see diagramm : EP0133673,P15,F2 in which A stands for hydrogen and B stands for hydrogen or hydroxy or A and B together form a bond, of the radicals R1 to R3 one stands for isovaleroyl, another stands for acetyl and the third stands for the acyl radical of one of the following acids : isovaleric acid, beta-methylvaleric acid, alpha-isovaleroyloxyisovaleric acid, alpha-acetoxyisovaleric acid, beta-acetoxyisovaleric acid, beta-acetoxy-beta-methylvaleric acid or beta-hydroxyisovaleric acid, and X stands for halogen, cyano, thiocyano, azido or an acyloxy radical R4 COO, in which R4 is an alkyl group, optionally substituted with hydroxy, with 1 to 20 carbon atoms or an alkenyl group with 3-20 carbon atoms or a phenyl, phenylalkyl or phenylalkenyl group with up to 3 carbon atoms in the alkylene or alkenylene chain, which may be optionally substituted in the phenyl ring with halogen, trifluoromethyl, hydroxy, lower alkyl or lower alkoxy, for the production of pharmaceutical preparations for the treatment and prophylaxis of peptic ulcers and/or for the treatment of spasmodic motility disorders in the gastrointestinal tract in larger mammals and humans. 1. Claims for the contracting State : AT Use of polyacyloxycyclopenta(c)pyran compounds of the general formula I see diagramm : EP0133673,P18,F1 in which A stands for hydrogen and B stands for hydrogen or hydroxy or A and B together form a bond, of the radicals R1 to R3 one stands for isovaleroyl, another stands for acetyl and the third stands for the acyl radical of one of the following acids : isovaleric acid, beta-methylvaleric acid, alpha-isovaleroyloxyisovaleric acid, alpha-acetoxyisovaleric acid, beta-acetoxyisovaleric acid, beta-acetoxy-beta-methylvaleric acid or beta-hydroxyisovaleric acid, and X stands for halogen, cyano, thiocyano, azido or an acyloxy radical R4 COO, in which R4 is an alkyl group, optionally substituted with hydroxy, with 1 to 20 carbon atoms or an alkenyl group with 3-20 carbon atoms or a phenyl, phenylalkyl or phenylalkenyl group with up to 3 carbon atoms in the alkylene or alkenylene chain, which may be optionally substituted in the phenyl ring with halogen, trifluoromethyl, hydroxy, lower alkyl or lower alkoxy, for the production of pharmaceutical preparations for the treatment and prophylaxis of peptic ulcers and/or for the treatment of spasmodic motility disorders in the gastrointestinal tract in larger mammals and humans.
HU842912A 1983-08-02 1984-07-30 Process for production of medical compositions containing new valepotriate-hydrinel and for production of new velopotriate HU201044B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833327811 DE3327811A1 (en) 1983-08-02 1983-08-02 NEW VALEPOTRIATHYDRINE-CONTAINING MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
HUT36109A true HUT36109A (en) 1985-08-28
HU201044B HU201044B (en) 1990-09-28

Family

ID=6205533

Family Applications (1)

Application Number Title Priority Date Filing Date
HU842912A HU201044B (en) 1983-08-02 1984-07-30 Process for production of medical compositions containing new valepotriate-hydrinel and for production of new velopotriate

Country Status (7)

Country Link
US (2) US4891384A (en)
EP (1) EP0133673B1 (en)
JP (1) JPS6054382A (en)
AT (1) ATE27911T1 (en)
DE (2) DE3327811A1 (en)
DK (1) DK372884A (en)
HU (1) HU201044B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
EP1700824A1 (en) * 2005-03-09 2006-09-13 Degussa AG Granules based on pyrogenically prepared silicon dioxide, method for their preparation and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1191515B (en) * 1963-01-26 1965-04-22 Kali Chemie Ag Process for obtaining sedative and spasmolytic esters from Radix valerianae
US3812154A (en) * 1969-12-08 1974-05-21 Kali Chemie Ag Dioxatricyclodecanes
US3917651A (en) * 1969-12-08 1975-11-04 Kali Chemie Ag Dioxatricyclodecanones
DE1961433C3 (en) * 1969-12-08 1974-06-06 Kali Chemie Ag S-alkoxy ^ -hydroxy-S-methyl-lOmethylene-2,9-dioxatricyclo- (4,3, l, 0 to the power of 3, to the power of 7) -decane and 8-alkoxy-4-hydroxy-3,10-dimethyl- 2,9dioxatricyclo- (4,3,1,0 to the power of 3Jioch 7) -decane and process for their preparation
US3987037A (en) * 1971-09-03 1976-10-19 Minnesota Mining And Manufacturing Company Chromophore-substituted vinyl-halomethyl-s-triazines
DE2230626B2 (en) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Valerian preparation
DE2654709C3 (en) * 1976-12-02 1987-07-09 A. H. Robins Co. Inc., Richmond, Va. Method for stabilizing valerian extract preparations
US4189323A (en) * 1977-04-25 1980-02-19 Hoechst Aktiengesellschaft Radiation-sensitive copying composition
JPS5928328B2 (en) * 1977-11-29 1984-07-12 富士写真フイルム株式会社 Photopolymerizable composition
DE2849029A1 (en) * 1978-11-11 1980-05-22 Kali Chemie Pharma Gmbh STABLE VALEPOTRIATE PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
DE3026579A1 (en) * 1980-07-14 1982-02-11 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-DIOXATRICYCLO (4,3,1, O (UP ARROW) 3,7 (UP ARROW)) DECANE
DE3112737A1 (en) * 1981-03-31 1982-10-07 Gehrlicher Kg Process for obtaining epoxide-free sedative agents from plants of the family Valerianaceae

Also Published As

Publication number Publication date
EP0133673B1 (en) 1987-06-24
US4891384A (en) 1990-01-02
HU201044B (en) 1990-09-28
US4980487A (en) 1990-12-25
ATE27911T1 (en) 1987-07-15
DE3464330D1 (en) 1987-07-30
DE3327811A1 (en) 1985-02-21
JPH0528235B2 (en) 1993-04-23
JPS6054382A (en) 1985-03-28
DK372884A (en) 1985-02-03
DK372884D0 (en) 1984-08-01
EP0133673A1 (en) 1985-03-06

Similar Documents

Publication Publication Date Title
FR2421874A1 (en) CARBOXYALKYLACYLAMINO ACIDS USEFUL AS HYPOTENSING AGENTS
FR2417500A1 (en) DERIVATIVES OF CYCLIC DEHYDROGENIC AMINO ACIDS AND THEIR THERAPEUTIC USE
FR2378521A1 (en) CARBOSTYRILE DERIVATIVES, USEFUL IN PARTICULAR AS STIMULANTS OF B-ADRENORECEPTOR CENTERS, AND THEIR PREPARATION PROCESS
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
IT1200011B (en) IMMUNOMODULATING AGENT
DE69728544D1 (en) TOTAL SYNTHESIS OF ACYL FULVENES WITH ANTITUARY EFFECT
DE3879787D1 (en) 11BETA-PHENYL-4,9,15-ESTRATRIENE, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
FR2372817A1 (en) DERIVATIVES OF THIAZOLIDINECARBOXYLIC ACIDS AND RELATED ACIDS, USEFUL AS ANTI-HYPERTENSION AGENTS
FR2392959A1 (en) AMINO ACIDS AND PROCESS FOR OBTAINING
DE3879429D1 (en) CYCLOPROPANDERIVATES.
DE3464330D1 (en) Medicaments containing valepotriathydrines
FR2430232A1 (en) NOVEL ARYLAMINOBENZOIC ACIDS USEFUL IN PARTICULAR AS HYPOGLYCEMATING AGENTS
FR2417499A1 (en) MERCAPTOACYLAMINO-HALOGEN ACIDS AND THEIR THERAPEUTIC USE
FR2422638A1 (en) NEW DERIVATIVES OF 3,3-DICHLORO-2-AZETIDINONE, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY AGENTS
ES2037077T3 (en) METHOD FOR PREPARING QUINONE-AMIDES.
UA19160A (en) A process for preparation of alkyl anilinofumarate
ES502137A0 (en) PROCEDURE FOR REFINING THE RAW CONDENSATION PRODUCT OF AMINOALKYLALCANOLAMINES
ATE60779T1 (en) N-GLYCOLYLNEURAMINIC ACID DERIVATIVE.
DE3175674D1 (en) Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
FR2374319A1 (en) SUBSTITUTE FURANNE- AND THIOPHENECARBALDEHYDES AND SUBSTITUTE FURYLALKYLCETONES AND SUBSTITUTE THIENYLALKYLCETONES, USE IN PARTICULAR AS ANTI-RHINOVIRUS AGENTS, AND THEIR PROCESS FOR PREPARATION
FR2396003A1 (en) NEWS 3 - ((4-CHROMANYLIDENE) AMINO) -2-OXAZOLIDINONES USEFUL IN PARTICULAR AS INHIBITORS OF GASTRIC SECRETION AND THEIR PROCESS FOR PREPARATION
FR2361338A1 (en) NEW O-AMINO-ALCOXYALCANES USEFUL AS VASODILATORS
FR2373549A1 (en) PROCESS FOR TRANSFORMATION OF 3-METHYLENECEPHALOSPORINS INTO 3-HETEROTHIOMETHYLCEPHALOSPORINS
ES2000782A6 (en) Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility.
ES2019551A6 (en) Process for obtaining derivatives of 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl-3-quinolinecarboxylic acid and derivatives of acrylate used in said process

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee